Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$664,470
New position
Shares Held
27,000
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#260
of 515 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Marex Group plc holds $79,745,220 across 11 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
973,771 | $33,760,640 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
3,250,000 | $31,947,500 | |
| 3 | GLAS |
Glass House Brands Inc.
|
750,000 | $9,750,000 | |
| 4 | ZTS |
Zoetis Inc.
|
16,395 | $1,178,144 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,351 | $732,012 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
27,000 | $664,470 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,900 | $504,812 | |
| 8 | VTRS |
Viatris Inc
|
30,931 | $491,184 |
All Filings in ELAN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $664,470 | 27,000 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||